We are excited to invite you to the upcoming EFCCA Conference "What do IBD patients find important in their treatment? - Results from a global Patient
Preference survey” that will take place on 20 February 2025 at the ECCO Congress in Berlin.
Registrations are open for the 1st GlycanTrigger Patients Symposium, an important event we are co-organising together with the Portuguese Society for Innovation (SPI), focused on collaborative discussions around strategies for predicting and preventing IBD.
We’re excited to present the latest issue of the EFCCA Magazine, now with a refreshed design! Inside, you’ll find an exclusive interview with Professor James Lee, who shares insights on his groundbreaking research into the causes of Inflammatory Bowel Disease (IBD).
EFCCA is excited to introduce a series of webinars, workshops and initiatives to be launched after the summer break.
We are pleased to announce the release of two significant reports that highlight our continuous efforts and achievements in advocating for improved IBD care and quality of life worldwide.
From 7 to 9 June 2024, Brussels hosted the European Federation of Crohn's and Ulcerative Colitis Associations (EFCCA) General Assembly, representing a significant event for our organisation.
On 12 October 2024, EFCCA organised a conference during UEG Week (Vienna) titled: "How can patients play a crucial role in medicines-related decision-making? An open dialogue with stakeholders and the presentation of the EFCCA HTA Guidebook."
We’re excited to present the latest issue of the EFCCA Magazine, now with a refreshed design! Inside, you’ll find an exclusive interview with Professor James Lee, who shares insights on his groundbreaking research into the causes of Inflammatory Bowel Disease (IBD).
Read the exclusive interview with Dr. James Lee, whose revolutionary research into a major cause of Inflammatory Bowel Disease (IBD) has been published in the Nature journal.
We’re excited to share our latest edition of the EFCCA Magazine! Discover how EFCCA and its members are making a difference locally and globally, from raising IBD awareness through impactful campaigns advocating for improved healthcare policies. Learn more about our partnerships involving the European Association of Hospital Pharmacists (EAHP), founding members and sister patient organisations of World IBD Day and our involvement in the EU Cross Border Clinical Trials Initiative (EU-X-CT Initiative).